Dephosphorylation of astrocyte elevated gene-1 protein upregulates eIF4E expression to promote gastric cancer progression
Protein phosphorylation modification plays an important role in regulating protein activity. Astrocyte elevated gene-1 (AEG-1), an adaptor protein, promotes the progression of various types of cancers by protein-protein interactions. We previously demonstrated that AEG-1 promoted the growth and metastasis of gastric cancer by upregulating the expression of oncogenic eukaryotic translation initiation factor 4E. However, a role for AEG-1 phosphorylation is not known. In this study, we identified phosphorylation of serines 426 (S426) and 308 (S308) as the inactive status of AEG-1. Decreased AEG-1 S426 phosphorylation in human gastric cancer tissues was correlated with the cancer progression, whereas AEG-1 S426 dephosphorylation upregulated eukaryotic translation initiation factor 4E transcription expression. This dephosphorylation was facilitated by AEG-1 S308 dephosphorylation through a mechanism involving the activation of p65 NF-κB. Double phosphorylation of AEG-1 S308-426 significantly inhibited the growth and migration of cancer cells while also suppressing the growth and metastasis of gastric cancer in nude mouse models. Mechanistically, the phosphatase protein 1 regulatory subunit 21 bound to AEG-1 and mediated the protein phosphatase 1 catalytic subunit to induce the loss of AEG-1 phosphorylation. Our findings highlight a role for AEG-1 dephosphorylation in the progression of gastric cancer and provide potential new targets for cancer therapy.
Authors
- Wenbin Huang (ORCID: https://orcid.org/0000-0002-0501-9785)
- Zhao Li (ORCID: https://orcid.org/0000-0003-1098-6742)
- Xuerong Wang (ORCID: https://orcid.org/0000-0002-3040-9435)
- Zuhao Zhang
- Yao‐Yao Fan (ORCID: https://orcid.org/0009-0008-4549-4100)
- Lin Yang (ORCID: https://orcid.org/0000-0002-9318-9812)
- Huiling Li (ORCID: https://orcid.org/0000-0002-1724-2087)
- Chen Chen (ORCID: https://orcid.org/0000-0003-2104-534X)
- Xixi Qian
- Shaorong Yu
Institutions
- Henan University of Science and Technology (CN)
- Jiangsu Cancer Hospital (CN)
- First Affiliated Hospital of Henan University of Science and Technology (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Journal of Biological Chemistry
- Published
- 2025-09-04
- DOI
- https://doi.org/10.1016/j.jbc.2025.110687
- Citations
- 1
- Primary Topic
- Cancer Mechanisms and Therapy
- Type
- article
- Field-Weighted Citation Impact
- 1.47
Funders
- Emory University
- National Natural Science Foundation of China
- Jiangsu Cancer Hospital